Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation

Resuscitation

Volumn 81, Issue 6, 2010, Pages 742-748

  Beiser, David G ^a   Wang, Huashan ^a   Li, Jing ^a   Wang, Xu ^b   Yordanova, Violeta ^c   Das, Anshuman ^a   Mirzapoiazova, Tamara ^a   Garcia, Joe G N ^a   Stern, Susan A ^b   Vanden Hoek, Terry L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CXCL1; Cytokine; Hemorrhagic shock; Inflammation; Interleukin 6; Keratinocyte derived chemokine; Nampt; Pre B cell colony enhancing factor; Resuscitation; Temperature; Tumor necrosis factor alpha; Visfatin

Indexed keywords

INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MYOGLOBIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HEART MUSCLE; HEMODYNAMICS; HEMORRHAGIC SHOCK; INDUCED HYPOTHERMIA; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESUSCITATION; SURVIVAL RATE; TISSUE LEVEL;

ANIMALS; CARDIOPULMONARY RESUSCITATION; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HYPOTHERMIA, INDUCED; ILEUM; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOGLOBIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SHOCK, HEMORRHAGIC; SURVIVAL RATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952890422     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.02.019     Document Type: Article

References (48)

1. Heckbert S.R., Vedder N.B., Hoffman W., et al. Outcome after hemorrhagic shock in trauma patients. J Trauma 1998, 45:545-549.
2. Keel M., Trentz O. Pathophysiology of polytrauma. Injury 2005, 36:691-709.
3. Yang S., Zheng R., Hu S., et al. Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function. Am J Physiol Heart Circ Physiol 2004, 287:H2183-2191.
4. Shahani R., Marshall J.G., Rubin B.B., Li R.K., Walker P.M., Lindsay T.F. Role of TNF-alpha in myocardial dysfunction after hemorrhagic shock and lower-torso ischemia. Am J Physiol Heart Circ Physiol 2000, 278:H942-950.
5. Martin C., Boisson C., Haccoun M., Thomachot L., Mege J.L. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997, 25:1813-1819.
6. McGlothlin J.R., Gao L., Lavoie T., et al. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 2005, 43:127-141.
7. Moitra J., Chiang E., Brown M., Singleton P., Garcia J. Extracellular PBEF induces endothelial cell proinflammatory gene expression via NF-kB activation. Am J Respir Crit Care Med 2009, 179. (1_MeetingAbstracts): A4179.
8. Hsu C.P., Oka S., Shao D., Hariharan N., Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 2009, 105:481-491.
9. Meyer D.M., Horton J.W. Effect of moderate hypothermia in the treatment of canine hemorrhagic shock. Ann Surg 1988, 207:462-469.
10. Prueckner S., Safar P., Kentner R., Stezoski J., Tisherman S.A. Mild hypothermia increases survival from severe pressure-controlled hemorrhagic shock in rats. J Trauma-Injury Infect Crit Care 2001, 50:253-262.
11. Kentner R., Rollwagen F.M., Prueckner S., et al. Effects of mild hypothermia on survival and serum cytokines in uncontrolled hemorrhagic shock in rats. Shock 2002, 17:521-526.
12. Takasu A., Norio H., Sakamoto T., Okada Y. Mild hypothermia prolongs the survival time during uncontrolled hemorrhagic shock in rats. Resuscitation 2002, 54:303-309.
13. Wu X., Stezoski J., Safar P., et al. Mild hypothermia during hemorrhagic shock in rats improves survival without significant effects on inflammatory responses. Crit Care Med 2003, 31:195-202.
14. Wu X., Kochanek P.M., Cochran K., et al. Mild hypothermia improves survival after prolonged, traumatic hemorrhagic shock in pigs. J Trauma 2005, 59:299-301. 291-299; discussion.
15. Becker L.B., Weisfeldt M.L., Weil M.H., et al. The PULSE initiative: scientific priorities and strategic planning for resuscitation research and life saving therapies. Circulation 2002, 105:2562-2570.
16. Anonymous American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2005, 112:1-203.
17. Zhao D., Abella B.S., Beiser D.G., et al. Intra-arrest cooling with delayed reperfusion yields higher survival than earlier normothermic resuscitation in a mouse model of cardiac arrest. Resuscitation 2008, 77:242-249.
18. Abella B., Zhao D., Alvarado J., Hamann K., Vanden Hoek T.L., Becker L. Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation 2004, 109:2786-2791.
19. Hsu C.Y., Huang C.H., Chang W.T., et al. Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction. Shock 2009, 32:210-216.
20. Vallejo J.G., Nemoto S., Ishiyama M., et al. Functional significance of inflammatory mediators in a murine model of resuscitated hemorrhagic shock. Am J Physiol Heart Circ Physiol 2005, 288:H1272-1277.
21. Crippen D., Safar P., Porter L., Zona J. Improved survival of hemorrhagic shock with oxygen and hypothermia in rats. Resuscitation 1991, 21:271-281.
22. Takasu A., Yanagawa Y., Sakamoto T., Okada Y. Therapeutic hypothermia limited to the resuscitation period does not prolong survival after severe hemorrhagic shock in rats. Resuscitation 2005, 67:119-126.
23. Mizushima Y., Wang P., Cioffi W.G., Bland K.I., Chaudry I.H. Restoration of body temperature to normothermia during resuscitation following trauma-hemorrhage improves the depressed cardiovascular and hepatocellular functions. Arch Surg 2000, 135:175-181.
24. Mizushima Y., Wang P., Cioffi W.G., Bland K.I., Chaudry I.H. Should normothermia be restored and maintained during resuscitation after trauma and hemorrhage? J Trauma 2000, 48:58-65.
25. Dubick M.A., Atkins J.L. Small-volume fluid resuscitation for the far-forward combat environment: current concepts. J Trauma 2003, 54:S43-45.
26. Stern S.A., Wang X., Mertz M., et al. Under-resuscitation of near-lethal uncontrolled hemorrhage: effects on mortality and end-organ function at 72h. Shock 2001, 15:16-23.
27. Stern S.A., Zink B.J., Mertz M., Wang X., Dronen S.C. Effect of initially limited resuscitation in a combined model of fluid-percussion brain injury and severe uncontrolled hemorrhagic shock. J Neurosurg 2000, 93:305-314.
28. Silbergleit R., Satz W., McNamara R.M., Lee D.C., Schoffstall J.M. Effect of permissive hypotension in continuous uncontrolled intra-abdominal hemorrhage. Acad Emerg Med 1996, 3:922-926.
29. Hierholzer C., Billiar T.R. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001, 386:302-308.
30. Giannoudis P.V., Hildebrand F., Pape H.C. Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 2004, 86:313-323.
31. Ayala A., Wang P., Ba Z.F., Perrin M.M., Ertel W., Chaudry I.H. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991, 260:R167-171.
32. Gundersen Y., Vaagenes P., Pharo A., Valo E.T., Opstad P.K. Moderate hypothermia blunts the inflammatory response and reduces organ injury after acute haemorrhage. Acta Anaesthesiol Scand 2001, 45:994-1001.
33. Naugler W.E., Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008, 14:109-119.
34. Yang S., Hu S., Hsieh Y.C., et al. Mechanism of IL-6-mediated cardiac dysfunction following trauma-hemorrhage. J Mol Cell Cardiol 2006, 40:570-579.
35. Frink M., Hsieh Y.C., Hsieh C.H., et al. Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage. Shock 2007, 28:576-581.
36. Fairchild K.D., Singh I.S., Patel S., et al. Hypothermia prolongs activation of NF-kappaB and augments generation of inflammatory cytokines. Am J Physiol Cell Physiol 2004, 287:C422-431.
37. Lecour S., Suleman N., Deuchar G.A., et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 2005, 112:3911-3918.
38. Vallejo J.G., Nemoto S., Ishiyama M., et al. Functional significance of inflammatory mediators in a murine model of resuscitated hemorrhagic shock. Am J Physiol Heart Circ Physiol 2005, 288.
39. Deitch E.A., Xu D., Franko L., Ayala A., Chaudry I.H. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1994, 1:141-145.
40. Rongvaux A., Shea R.J., Mulks M.H., et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002, 32:3225-3234.
41. Davutoglu M., Ozkaya M., Guler E., et al. Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices. Swiss Med Wkly 2009, 139:22-27.
42. Liu P., Li H., Cepeda J., et al. Critical role of PBEF expression in pulmonary cell inflammation and permeability. Cell Biol Int 2009, 33:19-30.
43. Liu S.W., Qiao S.B., Yuan J.S., Liu D.Q. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf) 2009, 71:202-207.
44. Ye S.Q., Zhang L.Q., Adyshev D., et al. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 2005, 70:142-151.
45. Ye S.Q., Simon B.A., Maloney J.P., et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury [see comment]. Crit Care Med 2005, 171:361-370.
46. Hong S.-B., Huang Y., Moreno-Vinasco L., et al. Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med 2008, 178:605-617.
47. Luk T., Malam Z., Marshall J.C. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008, 83:804-816.
48. Hausenloy D.J. Drug discovery possibilities from visfatin cardioprotection? Curr Opin Pharmacol 2009, 9:202-207.